Skip to content
The U.S. Food and Drug Administration (FDA) approved the Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults […]
FDA approves first drug that delays onset of type 1 diabetes Read More »
The dairy sector and the world’s food supply are suffering from extreme heat and increased disease risks to cows. Dairy cows are being stressed
Cows are stressed by heat – and we need to moo-ve to advance animal biotech solutions Read More »
We are about to hit the high point of the holiday season, and the Black Coalition Against COVID (BCAC) wants to ensure Black communities
Black Coalition Against COVID offers ‘plain’ talk about the holidays Read More »
In a breakthrough that could prove to be a powerful, life-saving tool against the opioid epidemic, a research team at the University of Houston
Fentanyl vaccine blocks the deadly opioid from entering the brain Read More »
A letter sent Wednesday by the Biotechnology Innovation Organization (BIO) and more than 150 groups working in health care calls on congressional leaders to
Current Congress urged to pass the PASTEUR Act Read More »
Biotechnology can provide solutions to the plastic pollution that is destroying our seas and streams—and opera can help too. Biotech solutions include plant-based bioplastics
I am BIO Podcast: Fighting pollution with microbes, bioplastics—and opera Read More »
BIO member Moderna’s bivalent Omicron-targeting boosters (mRNA-1273.214 and mRNA-1273.222) “trigger a superior antibody response” against Omicron (BA.4/BA.5) compared to its predecessor and also “met
Moderna’s updated COVID boosters create significantly more neutralizing antibodies Read More »
Senators Chuck Grassley (R-Iowa) and Joni Ernst (R-Iowa), both members of the Agriculture Committee, wrote to ask U.S. Trade Representative Katherine Tai to intervene
USTR must intervene in Mexico’s planned corn ban, Senators say Read More »
Australian biotech Vaxxas, which is developing patch dispensers for different diseases, announced earlier this month it has initiated a “Phase I clinical trial with
Vaxxas initiates clinical trial of its COVID-19 vaccine patch Read More »
Plans to put limits on the FDA’s Accelerated Approval pathway would reduce the number of new treatments hitting the market, with a particularly negative
